🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Informative and sobering dataset on CNS relapse of DLBCL from a large French-German collaboration just published in Leukemia Journal ~46% of pts with CNS relapse had a low CNS-IPI Most CNS relapses occur in the first year Still have a dismal prognosis nature.com/articles/s4137…

Kudos to Jaimal Kothari for leading one of the very few prospective trials post cBTKi in R/R WM. V important contribution to the WM field. PEMBRO-WM prospective phase II UK wide trial in British Journal of Haematology #lymsm #WM

A new BSH - Haematology Good Practice Paper on the prevention of CNS relapse in #LBCL has been published in light of growing controversy over the use of high-dose MTX for high-risk patients. Lead author Dr Matthew Wilson tells us more Matt Wilson thelimbic.com/uk/haematology…

This Blood Cancer Awareness Month, we’re launching a landmark new report: Taking blood cancer out of the shadows: A plan to increase survival, that details how blood cancer survival in the UK is being overshadowed 🩸

British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/bj…

CNS prophylaxis in large B-cell lymphomas: A balance with three pans Teresa Calimeri, Andrés J. M. Ferreri Commentary on: Wilson et al. CNS prophylaxis in LBCL: A BSH Good Practice Paper. Br J Haematol 2024 doi: 10.1111/bjh.19686 onlinelibrary.wiley.com/doi/full/10.11…

Brilliant to see off James McLaughlin this morning on the Glasgow leg of his amazing tour for Cure Leukaemia. Incredible effort (especially with an injury!) and for such an important cause 👏 👏 👏

BSH Lymphoma SIG MDT Dilemmas Live webinar Thurs 10Oct 1800-19:30 Management of asymp low tumour burden FL: Kirit Ardeshna & David Tucker Rx PMBL Andy Davies & ⁦Nicolas Martinez 🇨🇴🇨🇴⁩ NLPHL Rx dilemmas ⁦Pam McKay⁩ ⁦⁦Graham Collins⁩ b-s-h.org.uk/education/conf…

Impressive outcomes for ACOPP in older pts with Hodgkin. 41pts, 2y PFS 83%. Some toxicity seen though - 34% FN. great work from Matt Wilson and Pam McKay and coworkers. #ISHL13 #lymsm

Having learned every BSH - Haematology guideline off by heart for my FRCPath, it was very exciting to have been afforded the opportunity to lead an amazing group of co-authors for our GPP regarding bleomycin use in Hodgkin Lymphoma- published today! onlinelibrary.wiley.com/doi/10.1111/bj…

In patients with Hodgkin lymphoma, when should you avoid using Bleomycin and how should you manage pulmonary toxicity? Aisling Barrett and Graham Collins provide an excellent Good Practice Paper with answers OncoAlert #lymsm onlinelibrary.wiley.com/doi/10.1111/bj…

Amazing news of two new treatments approved for NHS use in Scotland: bloodcancer.org.uk/news/scotlands… Yescarta (axi-cel) as a second line lymphoma treatment Vanflyta (quizartinib) for newly-diagnosed AML Delighted to have played our part in championing blood cancer patients' needs

Glad to finally have axi-cel available in second line DLBCL for our patients in Scotland, ensuring equity across the UK. Thanks Blood Cancer UK

We have published a new GPP on the Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma ow.ly/bCtj50U48Hs

Time for biological-risk-informed real-time interventional studies. Time to be #RAdICAL Daniel Hodson Andrew Davies Sally Barrington Matt Wilson Graham Collins Wendy Sridhar Chaganti #WillTownsend et al Southampton CTU

Couldn't agree more! #RAdiCAL

🚨🚨🚨 The January 2025 edition of British Journal of Haematology is online. SEE HERE: onlinelibrary.wiley.com/toc/13652141/2… A multitude of outstanding contributions are within, including: 🔸 REVIEWS in #CML, #AML, #CLL & #transfusion medicine 🔸 BSH - Haematology GOOD PRACTICE PAPER on bleomycin in #HodgkinLymphoma

Nice to see this published... Is there still a role for CNS prophylaxis in diffuse large B-cell lymphoma? A debate with Dr Jeff Smith in The Lancet Haematology thelancet.com/journals/lanha…

It’s back and it’s online. The fantastic #lymphomaManagement course. With much thanks to LymphomaAction for their support as always. Do sign up to learn about state of the art management of this fascinating disease from international experts. #lymsm